JP2016517409A5 - - Google Patents

Download PDF

Info

Publication number
JP2016517409A5
JP2016517409A5 JP2016500472A JP2016500472A JP2016517409A5 JP 2016517409 A5 JP2016517409 A5 JP 2016517409A5 JP 2016500472 A JP2016500472 A JP 2016500472A JP 2016500472 A JP2016500472 A JP 2016500472A JP 2016517409 A5 JP2016517409 A5 JP 2016517409A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
linear
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500472A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016517409A (ja
JP6407951B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/019126 external-priority patent/WO2014158654A1/en
Publication of JP2016517409A publication Critical patent/JP2016517409A/ja
Publication of JP2016517409A5 publication Critical patent/JP2016517409A5/ja
Application granted granted Critical
Publication of JP6407951B2 publication Critical patent/JP6407951B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500472A 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法 Expired - Fee Related JP6407951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786020P 2013-03-14 2013-03-14
US61/786,020 2013-03-14
PCT/US2014/019126 WO2014158654A1 (en) 2013-03-14 2014-02-27 Ship1 modulators and methods related thereto

Publications (3)

Publication Number Publication Date
JP2016517409A JP2016517409A (ja) 2016-06-16
JP2016517409A5 true JP2016517409A5 (enExample) 2017-02-09
JP6407951B2 JP6407951B2 (ja) 2018-10-17

Family

ID=50288307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500472A Expired - Fee Related JP6407951B2 (ja) 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法

Country Status (14)

Country Link
US (2) US9765085B2 (enExample)
EP (1) EP2970122B1 (enExample)
JP (1) JP6407951B2 (enExample)
KR (3) KR20220110337A (enExample)
CN (2) CN105164108B (enExample)
AU (1) AU2014242041B2 (enExample)
BR (1) BR112015023009A2 (enExample)
CA (1) CA2902768A1 (enExample)
ES (1) ES2740779T3 (enExample)
IL (1) IL240968A0 (enExample)
MX (1) MX2015012111A (enExample)
RU (1) RU2679805C2 (enExample)
WO (1) WO2014158654A1 (enExample)
ZA (1) ZA201506674B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540353B2 (en) 2013-01-09 2017-01-10 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
RU2679805C2 (ru) 2013-03-14 2019-02-13 Экуинокс Фармасьютикалз (Кэнэда) Инк. Модуляторы ship1 и относящиеся к ним способы
HK1220173A1 (zh) 2013-03-14 2017-04-28 Aquinox Pharmaceuticals (Canada) Inc. Ship1调节剂和与其相关的方法
US9944590B2 (en) 2015-06-26 2018-04-17 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
US20190047939A1 (en) * 2016-03-02 2019-02-14 Patheon Austria Gmbh & Co Kg Process and intermediates for the production of 17(20)-ene b-seco steroids
WO2018126040A1 (en) 2016-12-28 2018-07-05 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol
EP4292655A2 (en) 2018-04-06 2023-12-20 Taro Pharmaceuticals Inc. Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation
CN112533905A (zh) * 2018-04-06 2021-03-19 塔罗制药公司 可用于治疗疼痛和炎症的茚衍生物
WO2019195777A1 (en) 2018-04-06 2019-10-10 Aquinox Pharmaceuticals (Canada) Inc. Indene derivatives useful in treating pain and inflammation
CN112940062B (zh) * 2021-02-23 2022-09-06 浙江神洲药业有限公司 一种16-去氢黄体酮的制备方法
CN117024374A (zh) * 2023-08-08 2023-11-10 安庆百谊生物科技有限公司 一种3-甲基-1,2,4-噻二唑-5-碳酰肼或其盐的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084718B (de) 1958-07-08 1960-07-07 Bayer Ag Verfahren zur Herstellung von Secosteroiden
SE345995B (enExample) 1969-01-31 1972-06-19 Bristol Myers Co
US3682983A (en) 1969-11-12 1972-08-08 Klaus Prezewowsky Preparation of {66 {11 {11 -17 ethinyl steroids
US3962275A (en) 1972-06-05 1976-06-08 Hoffmann-La Roche Inc. 7-oxa steroids
US3869467A (en) 1972-06-05 1975-03-04 Hoffmann La Roche 17-{62 -Hydroxy-17-{60 -methyl-5-{60 -androstano{9 3,2-c{9 or{8 2,3-d{9 isoxazoles
JPH01290624A (ja) 1988-05-16 1989-11-22 Shiono Chem Kk 5,6―セコ―ステロール誘導体血清脂質低下剤
US5543406A (en) 1991-12-20 1996-08-06 Glaxo Wellcome, Inc. Inhibitors of 5-α-testosterone reductase
JPH05221924A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール化合物
JPH05221901A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール誘導体
US5464866A (en) 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AP459A (en) 1992-12-18 1996-02-14 Glaxo Wellcome Inc Substituted 6-azaandrostenones.
DE69433220T2 (de) 1993-07-09 2004-08-19 Laboratoire Theramex Neue strukturelle Vitamin D Derivate
US5541322A (en) 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6046185A (en) 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
WO2000063323A1 (en) 1999-04-16 2000-10-26 Nippon Mitsubishi Oil Corporation Fluids for traction drive
AP1825A (en) 2000-04-28 2008-02-03 Inflazyme Pharm Ltd 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto.
NZ546612A (en) 2001-05-22 2007-08-31 Inflazyme Pharm Ltd Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation intermediates of this process
CA2463136A1 (en) 2001-10-17 2003-04-24 Raymond Andersen Ship 1 modulators
WO2004035601A1 (en) 2002-10-17 2004-04-29 The University Of British Columbia Ship 1 modulators
NZ542962A (en) 2003-04-15 2008-08-29 Inflazyme Pharm Ltd Indene derivatives as pharmaceutical agents
US20100323990A1 (en) 2006-06-21 2010-12-23 The University Of British Columbia Ship 1 modulator prodrugs
KR100950204B1 (ko) * 2006-09-26 2010-03-29 경북대학교 산학협력단 7α-아미노스테로이드 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 항암용 또는 항생제 조성물
EP2507221A1 (en) 2009-12-04 2012-10-10 Aquinox Pharmaceuticals Inc. Ship1 modulators and methods related thereto
ES2594980T3 (es) 2010-08-20 2016-12-27 The University Of British Columbia Moduladores de SHIP1 y métodos relacionados
JP2013545809A (ja) * 2010-12-13 2013-12-26 ラトガース ユニバーシティ 骨格筋および皮膚の成長、修復、および維持を促進するようにブラシノステロイドを産生および使用する方法
RU2679805C2 (ru) 2013-03-14 2019-02-13 Экуинокс Фармасьютикалз (Кэнэда) Инк. Модуляторы ship1 и относящиеся к ним способы
HK1220173A1 (zh) 2013-03-14 2017-04-28 Aquinox Pharmaceuticals (Canada) Inc. Ship1调节剂和与其相关的方法
US9944590B2 (en) 2015-06-26 2018-04-17 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
US20180085460A1 (en) 2016-09-26 2018-03-29 Aquinox Pharmaceuticals (Canada) Inc. Methods of treating prostatitis

Similar Documents

Publication Publication Date Title
JP2016517409A5 (enExample)
RU2015143676A (ru) Модулятолры ship1 и относящиеся к ним способы
JP6774513B2 (ja) ムスカリンm1受容体アゴニストとしての二環式アザ化合物
JP7626722B2 (ja) アミノピリミジンアミドオートファジー阻害剤およびその使用方法
JP6436205B2 (ja) キノリン誘導体
US10913727B2 (en) Modulators of the integrated stress pathway
JP5805763B2 (ja) C型肝炎ウイルス阻害剤
KR102534028B1 (ko) 트리아졸로피리미딘 화합물 및 그의 용도
RU2718917C2 (ru) Комбинированное лечение агонистом толл-подобного рецептора (tlr7) и ингибитором сборки капсида вируса гепатита в
SG11202111918PA (en) Substituted cycloalkyls as modulators of the integrated stress pathway
US12180193B2 (en) Accelerating fibrosarcoma protein degrading compounds and associated methods of use
CN108434149B (zh) 针对Rb阳性异常细胞增殖的HSPC节制性治疗
CN112312904A (zh) 螺环化合物
JP2020517667A (ja) 抗ウイルス剤としての融合インダゾールピリドン化合物
AU2018346597A1 (en) Inhibiting Ubiquitin Specific Peptidase 30
RU2018103944A (ru) Производные этинила как модуляторы метаботропного рецептора глутамата
EP3322711A1 (en) Hpk1 inhibitors and methods of using same
JP2018522034A5 (enExample)
TW201630891A (zh) 三環性螺化合物
WO2008016006A1 (fr) Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
AU2018240031A1 (en) Compounds and methods for the treatment of parasitic diseases
US20220064123A1 (en) (--)-Huperzine A Processes and Related Compositions and Methods of Treatment
EA036318B1 (ru) 6-аминопиридин-3-илтиазолы в качестве модуляторов rort
AU2019286531A1 (en) Pyrazole and imidazole compounds for inhibition of IL-17 and rorgamma
JP2017516772A5 (enExample)